The Utilization and Safety of Umeclidinium and Umeclidinium/Vilanterol in UK Primary Care: A Retrospective Cohort Study

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 1 news story.

UMEC is a long-acting muscarinic antagonist (LAMA) monotherapy and UMEC/VI is a dual therapy consisting of a LAMA and long-acting…